Cahill Represents Lead Arrangers in an Amendment to the Revolving Credit Facility for Catalent Pharma Solutions, Inc.
Date: 11/22/22
Cahill represented the lead arrangers in connection with an amendment to the revolving credit facility for Catalent Pharma Solutions, Inc., which, among other things, (i) extended the maturity date of the revolving credit commitments, and (ii) provided for a revolving commitment increase of $525,000,000, resulting in an aggregate revolving credit facility of $1,100,000,000 after giving effect to the amendment.